NCT01245790View on ClinicalTrials.gov

A Study of Fostamatinib in Subjects With Impaired Kidney Function

PHASE1CompletedINTERVENTIONAL

Enrollment

24

Participants

Timeline

Start Date

November 30, 2010

Primary Completion Date

June 30, 2011

Study Completion Date

June 30, 2011

Conditions

Rheumatoid ArthritisRenal Impairment

Interventions

DRUG

fostamatinib

Oral tablets, single dose

Trial Locations (1)

Unknown

Research Site, Orlando

Sponsors

Lead Sponsor

All Listed Sponsors

lead

AstraZeneca

INDUSTRY